Etidronsaeure
Brand names,
Etidronsaeure
Analogs
Etidronsaeure
Brand Names Mixture
Etidronsaeure
Chemical_Formula
C24H25NO4
Etidronsaeure
RX_link
http://www.rxlist.com/cgi/generic3/flavoxate.htm
Etidronsaeure
fda sheet
Etidronsaeure
msds (material safety sheet)
Etidronsaeure
Synthesis Reference
No information avaliable
Etidronsaeure
Molecular Weight
391.46 g/mol
Etidronsaeure
Melting Point
No information avaliable
Etidronsaeure
H2O Solubility
10 mg/L
Etidronsaeure
State
Solid
Etidronsaeure
LogP
4.636
Etidronsaeure
Dosage Forms
Tablets (100 mg)
Etidronsaeure
Indication
For symptomatic relief of dysuria, urgency, nocturia, suprapubic pain, frequency and incontinence as may occur in cystitis, prostatitis, urethritis, urethrocystitis/urethrotrigonitis.
Etidronsaeure
Pharmacology
Flavoxate is a spasmolytic flavone derivative that acts by relaxing the smooth muscle in the urinary tract. Flavoxate is a competitive muscarinic receptor antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. Muscarinic receptors play an important role in several major cholin-ergically mediated functions, including contractions of urinary bladder smooth muscle and stimulation of salivary secretion.
Etidronsaeure
Absorption
Well absorbed from gastrointestinal tract.
Etidronsaeure
side effects and Toxicity
The oral LD50 for flavoxate HCl in rats is 4273 mg/kg. The oral LD50 for flavoxate HCl in mice is 1837 mg/kg. Symptoms of overdose include convulsions, decreased ability to sweat, (warm, red skin, dry mouth, and increased body temperature), hallucinations, increased heart rate and blood pressure, and mental confusion.
Etidronsaeure
Patient Information
Etidronsaeure
Organisms Affected
Humans and other mammals